Evidence map›Paper›PMID 39021567›Full record

ArticleFrontiers in immunology2024

A non-invasive nanobody probe for high precision mapping of Lck spatial distribution.

Ioannis Tyritidis, Evangelos Tsioupros, Pantelis Christou, Nikolaos Koutras, Vasileios Morfos, Konstantina Nika

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ioannis TyritidisDepartment of Biochemistry, School of Medicine, University of Patras, Patras, Greece.
Evangelos TsiouprosDepartment of Biochemistry, School of Medicine, University of Patras, Patras, Greece.
Pantelis ChristouDepartment of Biochemistry, School of Medicine, University of Patras, Patras, Greece.
Nikolaos KoutrasDepartment of Biochemistry, School of Medicine, University of Patras, Patras, Greece.
Vasileios MorfosDepartment of Biochemistry, School of Medicine, University of Patras, Patras, Greece.
Konstantina NikaDepartment of Biochemistry, School of Medicine, University of Patras, Patras, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tyrosine kinase Lck is mandatory for initiating signaling responses downstream the antigenic T cell receptor (TCR). Numerous studies have shown that a prerequisite for efficient and well-balanced Lck regulation and function is its finely orchestrated spatial distribution pattern, especially at the plane of the plasma membrane. There is a wealth of knowledge on Lck localization sites, preference for specialized lipid microenvironments and colocalization partners. However, several questions concerning the spatial organization of its differentially phosphorylated conformers and the dynamics of their juxtaposition in relation to ligated and non-ligated TCRs remain elusive. In this brief report we introduce a non-invasive nanobody-based approach for mapping Lck subcellular allocation with high precision. Our initial data using this methodology, provide insight into the topology of Lck in resting T cells and its confined localization in a strictly delimited environment within the plane of the plasma membrane.

Indexed as

Lymphocyte Specific Protein Tyrosine Kinase p56(lck)Single-Domain AntibodiesCell MembraneHumansJurkat CellsPhosphorylationReceptors, Antigen, T-CellSignal TransductionT-LymphocytesLCK protein, humanLymphocyte Specific Protein Tyrosine Kinase p56(lck)Receptors, Antigen, T-CellSingle-Domain AntibodiesLckmembrane anchorsnanobodynon-invasive probeprotein localizationT cells

Identifiers

PMID39021567
PMCPMC11251914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.